|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
| We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/16/16 Emmaus Life Sciences, Inc. 10-Q 3/31/16 60:5.5M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 413K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
11: R1 Document and Entity Information HTML 44K
12: R2 Unaudited Condensed Consolidated Statements of HTML 65K
Operations
13: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 102K
14: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 37K
(Parenthetical)
15: R5 Unaudited Condensed Consolidated Statements of HTML 90K
Cash Flows
16: R6 Unaudited Condensed Consolidated Statements of HTML 48K
Stockholders' Deficit
17: R7 Nature of Operations HTML 34K
18: R8 Summary of Significant Accounting Policies HTML 80K
19: R9 Convertible Debt and Equity Financings HTML 64K
20: R10 Derivative Liabilities HTML 54K
21: R11 Stockholders' Deficit HTML 120K
22: R12 Related Party Transactions HTML 72K
23: R13 Loss Per Share HTML 47K
24: R14 Commitments and Contingent Liabilities HTML 50K
25: R15 Subsequent Events HTML 30K
26: R16 Summary of Significant Accounting Policies HTML 133K
(Policies)
27: R17 Summary of Significant Accounting Policies HTML 52K
(Tables)
28: R18 Convertible Debt and Equity Financings (Tables) HTML 44K
29: R19 Derivative Liabilities (Tables) HTML 48K
30: R20 Stockholders' Deficit (Tables) HTML 107K
31: R21 Related Party Transactions (Tables) HTML 29K
32: R22 Loss Per Share (Tables) HTML 44K
33: R23 Commitments and Contingent Liabilities (Tables) HTML 32K
34: R24 Nature of Operations (Details Narrative) HTML 40K
35: R25 Summary of Significant Accounting Policies HTML 26K
(Details)
36: R26 Summary of Significant Accounting Policies HTML 31K
(Details 1)
37: R27 Summary of Significant Accounting Policies HTML 54K
(Details Narrative)
38: R28 Convertible Debt and Equity Financings (Details) HTML 84K
39: R29 Convertible Debt and Equity Financings (Details HTML 189K
Narrative)
40: R30 Derivative Liabilities (Details) HTML 31K
41: R31 Derivative Liabilities (Details 1) HTML 41K
42: R32 Derivative Liabilities (Details Narrative) HTML 70K
43: R33 Stockholders' Deficit (Details) HTML 27K
44: R34 Stockholders' Deficit (Details 1) HTML 40K
45: R35 Stockholders' Deficit (Details 2) HTML 87K
46: R36 Stockholders' Deficit (Details 3) HTML 40K
47: R37 Stockholders' Deficit (Details 4) HTML 67K
48: R38 Stockholders' Deficit (Details 5) HTML 33K
49: R39 Stockholders' Deficit (Details Narrative) HTML 118K
50: R40 Stockholders' Deficit (Details Narrative 1) HTML 40K
51: R41 Related Party Transactions (Details) HTML 49K
52: R42 Related Party Transactions (Details Narrative) HTML 188K
53: R43 Related Party Transactions (Details Narrative 1) HTML 238K
54: R44 Loss Per Share (Details) HTML 39K
55: R45 Commitments and Contingent Liabilities (Details) HTML 54K
56: R46 Commitments and Contingent Liabilities (Details HTML 70K
Narrative)
57: R47 Subsequent Events (Details Narrative) HTML 86K
59: XML IDEA XML File -- Filing Summary XML 106K
58: EXCEL IDEA Workbook of Financial Reports XLSX 82K
5: EX-101.INS XBRL Instance -- cnso-20160331 XML 1.81M
7: EX-101.CAL XBRL Calculations -- cnso-20160331_cal XML 124K
8: EX-101.DEF XBRL Definitions -- cnso-20160331_def XML 723K
9: EX-101.LAB XBRL Labels -- cnso-20160331_lab XML 927K
10: EX-101.PRE XBRL Presentations -- cnso-20160331_pre XML 883K
6: EX-101.SCH XBRL Schema -- cnso-20160331 XSD 141K
60: ZIP XBRL Zipped Folder -- 0001615774-16-005455-xbrl Zip 141K
EXHIBIT 31.1
Certification of CEO Pursuant to
Securities Exchange Act Rules 13a-14 and 15d-14
as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, George Carpenter, certify that:
1. I have reviewed this quarterly report on Form 10-Q of MYnd Analytics, Inc. for the quarter ended March 31, 2016;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: May 16, 2016
| /s/ George Carpenter | |
| Name: George Carpenter | |
| Title: Chief Executive Officer (Principal Executive Officer) |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/16/16 | |||
| For Period end: | 3/31/16 | 4, 8-K | ||
| List all Filings | ||||